Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.
about
A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue SarcomaSystemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and EribulinSystemic treatment in advanced soft tissue sarcoma: what is standard, what is new.Update on the role of trabectedin in the treatment of intractable soft tissue sarcomasEfficacy of bortezomib in sarcomas with high levels of MAP17 (PDZK1IP1).Metastatic soft tissue sarcoma: current treatment landscape and future perspectives.Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma.Soft Tissue and Uterine Leiomyosarcoma.Systemic Treatment for Adults with Synovial Sarcoma.Apatinib for advanced sarcoma: results from multiple institutions' off-label use in China.Secondary cytoreductive surgery potentially improves the oncological outcomes of patients with recurrent uterine sarcomas.Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.
P2860
Q26741817-89BD8504-62FD-442C-973B-30F431CFF02BQ33890846-7F21620C-904D-44D5-A7A0-97DB69329004Q36389964-B1AF4051-C76A-40ED-9BDC-7C1F7D1A5139Q37669484-F94B8F9C-F2B8-49E5-B16D-F4D71DC8F175Q37687113-94E47AFA-6A96-4DAF-B6CB-CFF5AB598688Q38692839-F7D186CC-2656-4EAB-86B7-268B95DFB59CQ38769613-1503AF79-5CC9-4442-9C46-E03F95E4A0A7Q41712411-06558A73-EF7C-4FD3-BF54-B217648A8934Q50004094-F9FF7E39-00EE-48A5-A02A-C4E8812CFB66Q52667763-4F2D332A-355F-41D2-93CA-8AF87DDA0CB2Q54117193-52050327-8D8E-49B3-9FE6-658D45E80D8FQ55124822-23BFB303-DCA4-4A00-A56D-0E1ACF4BB842Q55365628-43FCA388-1DD8-4C88-B51B-4BE75131AD63
P2860
Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Randomized Phase II Study of T ...... for Research on Sarcoma Study.
@ast
Randomized Phase II Study of T ...... for Research on Sarcoma Study.
@en
type
label
Randomized Phase II Study of T ...... for Research on Sarcoma Study.
@ast
Randomized Phase II Study of T ...... for Research on Sarcoma Study.
@en
prefLabel
Randomized Phase II Study of T ...... for Research on Sarcoma Study.
@ast
Randomized Phase II Study of T ...... for Research on Sarcoma Study.
@en
P2093
P356
P1476
Randomized Phase II Study of T ...... for Research on Sarcoma Study
@en
P2093
Ana De Juan
Andrés Poveda
Andrés Redondo
Antonio Gutierrez
Antonio López Pousa
Isabel Sevilla
Javier Martin-Broto
Javier Martinez-Trufero
Joan Maurel
Jordi Martinez-Serra
P304
P356
10.1200/JCO.2015.65.3329
P407
P577
2016-05-16T00:00:00Z